Literature DB >> 4365230

Cytoplasmic glucocorticoid-binding proteins in glucocorticoid-unresponsive human and mouse leukemic cell lines.

M E Lippman, S Perry, E B Thompson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365230

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  [Immunopharmacology of corticosteroids].

Authors:  L H Block; W Vetter; W Siegenthaler
Journal:  Klin Wochenschr       Date:  1982-11-15

2.  Glucocorticoid receptors and lymphocytolysis in normal and neoplastic lymphocytes.

Authors:  R W Turnell; A F Burton
Journal:  Mol Cell Biochem       Date:  1975-12-31       Impact factor: 3.396

3.  Dexamethasone binding to chromatin, inhibition of in vitro RNA synthesis, and therapeutic effect on human lymphosarcoma.

Authors:  N van der Meulen; G Prindull; K Lipp; J F Winge
Journal:  Klin Wochenschr       Date:  1980-06-16

4.  Proceedings: Cultured lymphoblastoid lines as a model for leukaemia/lymphoma.

Authors:  C M Steel
Journal:  Br J Cancer       Date:  1975-08       Impact factor: 7.640

5.  Cytoplasmic receptor levels and glucocorticoid response in human lymphoblastoid cell lines.

Authors:  C C Bird; A W Waddell; A M Robertson; A R Currie; C M Steel; J Evans
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

6.  Immunosuppression with glucocorticoids--a possible immunological explanation for interpatient variation in sensitivity: discussion paper.

Authors:  J S Beck; M C Browning
Journal:  J R Soc Med       Date:  1983-06       Impact factor: 18.000

7.  Terminal deoxynucleotidyl transferase activities and glucocorticoid receptors in leukaemia.

Authors:  R Sasaki; F Takaku; T Aoki; F J Bollum; T Saito; S Dan
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640

8.  Dual Mechanisms of Metabolism and Gene Expression of the CCRF-CEM Leukemia Cells under Glucocorticoid Treatment.

Authors:  George I Lambrou; Theodoros Karakonstantakis; Spiros Vlahopoulos; Apostolos Zaravinos
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.